These 3 AI Stocks Are Still the Best Buys for 2026
For some, the recent tech sell-off is just the start of a much-needed correction, or more pessimistically, even…
AMD Selloff After Record Results Raises Questions On AI Growth Timing
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. AMD…
How Recent AI And Power Moves Are Reshaping The IREN (IREN) Investment Story
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices
Feb 4 (Reuters) – GE HealthCare on Wednesday forecast annual profit above Wall Street estimates, betting on robust…
This Artificial Intelligence (AI) Play Could Be the Steal of 2026
Finding steals in the stock market isn’t easy, but they are available. Sometimes, they’re right under your nose!…
Could This Artificial Intelligence (AI) Stock Double in 2026?
Finding and identifying stocks that have the potential to double in a year is no easy feat. However,…
2 AI Stocks Will Be Worth More Than Nvidia and Palantir Technologies Combined by 2028
Nvidia and Palantir Technologies are collectively worth $4.9 trillion; Amazon and Alphabet could exceed that figure by the…
Afraid You Missed the AI Boom? This Late-Cycle Winner Could Be Your Second Chance.
While Nvidia’s GPUs helped power the AI boom, priorities have begun to shift. Data centers and other hyperscale…
Better Artificial Intelligence Stock: Nvidia vs. Meta Platforms
Nvidia is the leading AI chip designer. Meta is developing AI and applying it to its business. Both…
Assessing Strive Asset Management (ASST) Valuation After Recent Share Price Weakness
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
TSMC’s Strong Outlook Fires Up Hopes of Sustained AI Boom
Bloomberg, company filings (Bloomberg) — Taiwan Semiconductor Manufacturing Co. is earmarking as much as $56 billion in capital…
JPM26: J&J reveals oncology strategy
CEO Joaquin Duato presented a strong outlook for Johnson & Johnson’s (J&J) revenue growth in 2026, with particular…